Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Dual effects of RAS blockade on blood pressure and podocyte function
Jochen Reiser
, Peter Mundel
Research output
:
Contribution to journal
›
Review article
›
peer-review
35
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Dual effects of RAS blockade on blood pressure and podocyte function'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Blood Pressure
100%
Dual Effect
100%
Podocyte
100%
Renin-angiotensin System Blockade
100%
Cardiovascular Disease
33%
Renin-angiotensin System
33%
Chronic Kidney Disease
33%
Hypertension
16%
Diabetic
16%
Kidney
16%
Angiotensin-converting Enzyme Inhibitor (ACEi)
16%
Independent Risk Factors
16%
Functional Integrity
16%
Structural Integrity
16%
Non-diabetic
16%
Blood Pressure Lowering
16%
Calcium Signaling
16%
Proteinuria
16%
Pressure Dependence
16%
Hypertension Risk
16%
Kidney Disease Progression
16%
Normal Renal Function
16%
Podocyte Injury
16%
Angiotensin II Type 1 Receptor Blocker
16%
Pericyte-like Cells
16%
Glomerular Filter
16%
Pharmacology, Toxicology and Pharmaceutical Science
Renin
100%
Angiotensin
100%
Chronic Kidney Failure
75%
Cardiovascular Disease
50%
Injury
25%
Diabetes Mellitus
25%
Dipeptidyl Carboxypeptidase Inhibitor
25%
Proteinuria
25%
Angiotensin 1 Receptor Antagonist
25%
Biochemistry, Genetics and Molecular Biology
Blood Pressure
100%
Renin Angiotensin Aldosterone System
100%
Podocyte
100%
Enzyme Inhibitor
14%
Kidney Function
14%
Pericyte
14%
Angiotensin-Converting Enzyme
14%
Calcium Signaling
14%
Angiotensin II Receptor Type 1
14%